Test Price
2,800 AED✅ Home Collection Available
SLC35C1 Gene Genetic Test (Leukocyte Adhesion Deficiency Type II / CDG Type IIc) in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين SLC35C1 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – ملخص تنفيذي: اختبار DNA جيني عالي الدقة لنقص تصنيع السكر من النوع الثاني C، معتمد من هيئة الصحة بدبي ومطابق للمعايير الدولية 2026.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015‑accredited NGS processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Telephonic post‑test clinical guidance for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Overview
SLC35C1 gene NGS testing identifies pathogenic variants responsible for leukocyte adhesion deficiency type II (LAD II) / congenital disorder of glycosylation type IIc, a rare multisystem disorder with neurological and immunological manifestations. تقوم هذه الفحوصات الجينية بتحديد الطفرات المسببة لاضطراب نقص تصنيع السكر من النوع الثاني C.
| Parameter | Our Test (NGS) | Closest Alternative (Sanger) |
|---|---|---|
| Precision / Sensitivity | 99.9% (full gene coverage) | Limited to known familial mutation |
| Methodology | Next‑Generation Sequencing (NGS) with CNV analysis | Targeted Sanger sequencing, no CNV detection |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| DHA/MOHAP Compliance | Full (license 9834453) | Variable |
Physician Insight & Safety Protocol
“As a clinical geneticist, I emphasize that this SLC35C1 test must be interpreted alongside comprehensive clinical evaluation and family history. النتائج الجينية ليست تشخيصًا نهائيًا بذاتها. Please do not make any treatment decisions without a specialist consultation.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Abrupt changes are dangerous and may worsen underlying conditions.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria
- Active severe infection or acute febrile illness (may compromise sample integrity).
- Recent blood transfusion (wait ≥2 weeks) or bone marrow transplant.
- Pregnant women seeking urgent invasive prenatal diagnosis (this test is not designed for rapid prenatal decisions).
- Inability to provide informed consent or attend mandatory genetic counseling session.
Emergency Red Flags – Call 998 Immediately
- Sudden neurological deterioration (seizures, loss of consciousness).
- Severe recurrent infections with signs of sepsis (high fever, chills, hypotension).
- Acute metabolic decompensation (vomiting, lethargy, hypoglycemia).
Patient FAQ & Clinical Guidance
1. What is the SLC35C1 gene test and why is it important?
Snippet: This NGS test identifies SLC35C1 gene mutations to accurately diagnose leukocyte adhesion deficiency type II and CDG type IIc. (يستخدم هذا الفحص تقنية التسلسل الجيني للكشف عن الطفرات المرتبطة باضطراب نقص التصاق الكريات البيضاء من النوع الثاني.)
2. How should I prepare for the?
Snippet: Provide a detailed medical history and family pedigree during a mandatory genetic counseling session prior to sample collection. (يجب تقديم تاريخ طبي كامل ورسم شجرة عائلة خلال جلسة استشارة وراثية.)
3. What do the results mean and what are the next steps?
Snippet: A positive result indicates a disease‑causing variant necessitating clinical correlation; a negative result significantly reduces but does not completely exclude the condition. (النتيجة الإيجابية تستدعي استشارة طبية متخصصة للتخطيط العلاجي.)
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians